Search results
If you are looking for research summaries please go to the research summary page.
- Still got questions?
- TemplatesThe introduction of the GDPR brings with it stricter requirements around how organisations inform people of how their personal data is being used. We have drafted a series of templates to help organisations meet this requirement.
- Patient data and research leaflet
- GDPR transparency wording for all sponsors
- Template email for sponsors sharing a GDPR amendment
- Transparency information for NHS sites
- GDPR: technical guidanceWe've worked with partners to develop Technical Guidance intended for Data Protection Officers (DPO), research managers, information governance or security architecture leads, or equivalent roles. It may also be relevant to researchers.
- GDPR technical guidance: lawful basis
- GDPR technical guidance: safeguards
- GDPR technical guidance: transparency
- GDPR technical guidance: data subject rights and research exemptions
- GDPR technical guidance: What you should do now
- Ionising radiationUnder the Ionising Radiation (Medical Exposure) Regulations 2000 (“IRMER”) and subsequent amendments, ethical approval is required by a Research Ethics Committee (REC) where any of the procedures in the research protocol involves exposure to ionising radiation and the participants are involved in medical or biomedical, diagnostic or therapeutic, research programmes.
- Prison researchFor this purpose, a prisoner or young offender is defined as any inmate of the prison systems of England and Wales, Scotland or Northern Ireland. It does not include patients detained under the Mental Health Act at special hospitals or other psychiatric secure units, or juvenile offenders detained in local authority secure accommodation or secure training centres.
- Research involving childrenThere are many ethical and legal issues to consider when involving children and young people in research.
- Phase 1 clinical trialsAll investigational medicinal products (IMPs) go through a series of trials before they can be licensed for use.
- Long description for Phase 1 application process
- Generic screening of potential Phase 1 trial participants: guidance for using the HRA generic screening information sheet and consent form template
- Research tissue banks and research databasesIf you are planning to create a research database or a research tissue bank (‘biobank’) then the following information may be helpful.
- Research Tissue Banks FAQs